Blog
123 Articles
What Happens When Pancreatic Cancer Clinical Trials Fail?
Why do clinical trials fail? What about the patients on the trial? Learn more about what happens when pancreatic cancer clinical trials fail.
Each Person Is a Statistic of One
When Miggie Olsson was diagnosed with stage IV pancreatic cancer she opted for a science-based unusual treatment plan to have a chance at survival.
Tumor RNA Testing Leads to Treatment with a New Drug
When treatment stopped working for Adam Deal, genetic testing of his tumor RNA found a mutation that made him eligible to try a new drug.
I’ll Never Stop Fighting
When Lynne Holcomb was diagnosed with stage IV pancreatic cancer, she kept fighting through treatment and made it onto a clinical trial.
The Diabetes and Pancreatic Cancer Connection
Professor Dr. Suresh Chari explains the link between newly on-set diabetes as an indication of pancreatic cancer. Read Dr. Chari’s findings to learn more.
New Study Combines Checkpoint Inhibitors with Radiation Therapy to Boost Immune Response
Dr. Theodore Hong combines checkpoint inhibitors–a type of immunotherapy–with radiation to boost the immune system in pancreatic cancer treatment.
New Study Focuses On Supportive Oncology Care At Home
Dr. Ryan Nipp is exploring the value of supportive oncology care at home for pancreatic cancer patients in a pilot clinical trial.
Relocating For Pancreatic Cancer Treatment and a Clinical Trial
Rachel Moreno knew she would need help during treatment but moving in with her son also gave her access to a clinical trial.
Molecular Profiling Leads to Non-Standard Pancreatic Cancer Treatments
With stage IV pancreatic cancer, Rick Baker got molecular profiling which helped direct his different treatments, including clinical trials.
Combination Delivers a Dual Punch to Pancreatic Cell Growth
Dr. Conan Kinsey outlines a clinical trial that has moved quickly from the lab to phase I, with a dual approach to delivering pancreatic cancer treatment.
A PARP Inhibitor Approval for Pancreatic Cancer
PARP inhibitors, a type of targeted therapy, are being studied as treatment for pancreatic cancer in a number of clinical trials.
A Clinical Trial for a Rare Pancreatic Cancer
Allison Lippman Kuban was trying to tolerate a difficult chemotherapy regimen when a mutation was found that qualified her for a clinical trial.
The Positive Impact of a Pancreatic Cancer Clinical Trial
Richard Blish was a healthy, athletic 67-year-old when he developed symptoms of pancreatic cancer. His daughter steered him to a clinical trial for treatment.
Living with Pancreatic Cancer as a Long-Term Survivor
Roberta Luna has been fighting pancreatic cancer since 2002, but the disease has been part of her life for much longer. Read about her battle.
I Have So Much to Live For
Mary Gillam knew that she had to fight after her pancreatic cancer diagnosis. She traveled to where she would get the best treatment and a clinical trial.